Remdesivir and COVID-19.
作者信息
Glaus Matthew J, Von Ruden Serena
机构信息
St. Francis Hospital, Federal Way, WA 98003, USA.
St. Francis Hospital, Federal Way, WA 98003, USA.
出版信息
Lancet. 2020 Oct 3;396(10256):952. doi: 10.1016/S0140-6736(20)32021-3.
Abstract
摘要
相似文献
1
Remdesivir and COVID-19.瑞德西韦与新型冠状病毒肺炎
Lancet. 2020 Oct 3;396(10256):952. doi: 10.1016/S0140-6736(20)32021-3.
2
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.支持瑞德西韦治疗新型冠状病毒感染的论据。
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
3
Compassionate Use of Remdesivir in Covid-19.瑞德西韦在新冠疫情中的同情用药
N Engl J Med. 2020 Jun 18;382(25):e101. doi: 10.1056/NEJMc2015312. Epub 2020 May 15.
4
Compassionate Use of Remdesivir in Covid-19.瑞德西韦在新冠疫情中的同情用药
N Engl J Med. 2020 Jun 18;382(25):e101. doi: 10.1056/NEJMc2015312. Epub 2020 May 15.
5
Compassionate Use of Remdesivir in Covid-19.瑞德西韦在新冠疫情中的同情用药
N Engl J Med. 2020 Jun 18;382(25):e101. doi: 10.1056/NEJMc2015312. Epub 2020 May 15.
6
Compassionate Use of Remdesivir in Covid-19.瑞德西韦在新冠病毒病中的同情用药
N Engl J Med. 2020 Jun 18;382(25):e101. doi: 10.1056/NEJMc2015312. Epub 2020 May 15.
7
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.瑞德西韦的紧急使用授权：透明分配流程的必要性。
JAMA. 2020 Jun 16;323(23):2365-2366. doi: 10.1001/jama.2020.8863.
8
Compassionate Use of Remdesivir in Covid-19. Reply.瑞德西韦在新冠病毒病中的同情用药。回复。
N Engl J Med. 2020 Jun 18;382(25):e101. doi: 10.1056/NEJMc2015312. Epub 2020 May 15.
9
Remdesivir and COVID-19.瑞德西韦与新型冠状病毒肺炎
Lancet. 2020 Oct 3;396(10256):953. doi: 10.1016/S0140-6736(20)32020-1.
10
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?我们用瑞德西韦（一种老药新包装）找到了治疗新冠病毒肺炎的万灵药了吗？
J R Coll Physicians Edinb. 2020 Jun;50(2):159-161. doi: 10.4997/JRCPE.2020.217.
引用本文的文献
1
Recapitulating Trafficking of Nucleosides Into the Active Site of Polymerases of RNA Viruses: The Challenge and the Prize.概述核苷转运至RNA病毒聚合酶活性位点的过程：挑战与收获。
Front Med Technol. 2021 Dec 14;3:705875. doi: 10.3389/fmedt.2021.705875. eCollection 2021.
2
Riding the COVID Waves: Clinical Trends, Outcomes, and Remaining Pitfalls of the SARS-CoV-2 Pandemic: An Analysis of Two High-Incidence Periods at a Hospital in Northern Italy.应对新冠浪潮：SARS-CoV-2大流行的临床趋势、结果及尚存的问题：意大利北部一家医院两个高发期的分析
J Clin Med. 2021 Nov 11;10(22):5239. doi: 10.3390/jcm10225239.
3
Higher entropy observed in SARS-CoV-2 genomes from the first COVID-19 wave in Pakistan.在巴基斯坦首次 COVID-19 浪潮中观察到的 SARS-CoV-2 基因组中存在更高的熵。
PLoS One. 2021 Aug 31;16(8):e0256451. doi: 10.1371/journal.pone.0256451. eCollection 2021.
4
Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial.褪黑素对 COVID-19 患者睡眠质量和结局的影响：一项开放标签、随机、对照试验。
J Med Virol. 2022 Jan;94(1):263-271. doi: 10.1002/jmv.27312. Epub 2021 Sep 8.
5
COVID-19, corticosteroids and public health: a reappraisal.COVID-19、皮质类固醇和公共卫生：重新评估。
Public Health. 2021 Aug;197:48-55. doi: 10.1016/j.puhe.2021.05.028. Epub 2021 Jun 7.
6
Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver.新冠病毒病治疗的现有及新型药物及其对肝脏的影响
J Clin Transl Hepatol. 2021 Jun 28;9(3):436-446. doi: 10.14218/JCTH.2020.00174. Epub 2021 Apr 19.
7
Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study.RNA病毒药物对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）蛋白的抑制效果：一项广泛研究。
J Mol Struct. 2021 Jun 15;1234:130152. doi: 10.1016/j.molstruc.2021.130152. Epub 2021 Feb 26.
8
Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection.针对冠状病毒感染的实验或临床验证药物的本体论建模和分析。
Sci Data. 2021 Jan 13;8(1):16. doi: 10.1038/s41597-021-00799-w.
Zotero 插件